# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-122279
Filing Date
2023-04-27
Accepted
2023-04-27 16:26:52
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d479050dars.pdf | ARS | 3377053
| Complete submission text file | 0001193125-23-122279.txt |  | 4606161

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40551 | Film No.: 23857446
SIC: 2836 Biological Products, (No Diagnostic Substances)